Cargando…
Personalising cancer medicine with prognostic markers
Autores principales: | Kerr, David J, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477141/ https://www.ncbi.nlm.nih.gov/pubmed/34563926 http://dx.doi.org/10.1016/j.ebiom.2021.103577 |
Ejemplares similares
-
Personalised Medicine - Bringing Innovation to the Healthcare System
por: Horgan, Denis, et al.
Publicado: (2017) -
New tricks with old dogs: personalised medicine and clinical trials
por: Koziol, J A
Publicado: (2011) -
How personalised medicine will transform healthcare by 2030: the ICPerMed vision
por: Vicente, Astrid M., et al.
Publicado: (2020) -
Smart Medication Adherence Monitoring in Clinical Drug Trials: A Prerequisite for Personalised Medicine?
por: Zijp, Tanja R., et al.
Publicado: (2019) -
Personalised Medicine in Europe
por: Andriukaitis, Vytenis
Publicado: (2017)